Skip to content
FusionBenchmark
SHINE Technologies — image published by the organisation
Published by SHINE Technologies source ↗
SHINE Technologies

SHINE Technologies

Discover SHINE Technologies' innovative approach to fusion technology, producing medical isotopes, recycling nuclear waste, and generating energy.

Sector
Fusion, Supply chain

163 in this dataset · 50 in this dataset

Technology
Beam-target

3 developers pursuing it

Fuel
Deuterium–tritium
Headquarters
🇺🇸Janesville, US

103 organisations in US

Founded
2010
Status
Active
Role
Fusion developer, Supplier

What these terms mean

Every classification on this page, defined. These are controlled-vocabulary terms, so the same word means the same thing on every profile.

Fusion developer
Develops a fusion device or power plant concept. Carries no implication that the device exists or works.
Supplier
Supplies components, materials or fuel to the sector without developing a reactor or device of its own.
Fusion
Organizations pursuing energy from nuclear fusion, and their dedicated supply chain.
Supply chain
Components, materials, instrumentation and services sold into fusion or fission programmes.
Beam-target › Beam-target
Net-energy-incapable by construction, but commercially relevant for neutron and isotope production.
Deuterium–tritium
Lowest ignition threshold; 80% of energy in 14.1 MeV neutrons. The reference fuel for every near-term net-gain claim.

In SHINE Technologies’s own words

Quoted from the organisation’s own site as we archived it. Their description of themselves, not ours, and not a claim this site has checked.

While most fusion companies chase next-generation power plants, SHINE operates fusion technology at industrial scale now. Our fusion systems sustain record steady-state neutron output. Our radiochemistry capabilities separate isotopes with speed and precision. As a result, we’re delivering value to customers while establishing the technical foundation for commercial fusion power. Here are the technologies making this possible—and the innovations paving the way to a fusion-powered future.

High-current particle beams strike a tritium gas target, producing an intense flow of neutrons that can drive a range of applications, from isotope production to radiation effects testing to nuclear waste transmutation. We design, build, and operate these systems in-house through our Systems and Manufacturing team. They integrate particle accelerators, fusion targets, and radiochemical processing into equipment that runs at production scale. This combination of fusion physics and manufacturing know-how is what enables us to deploy fusion commercially.

Cancer care and diagnostic imaging depend on isotopes that the U.S. has long imported from aging overseas reactors. To strengthen supply, we’re building next-generation facilities to produce these vital isotopes for patients and providers worldwide.

Our fusion production platform will make Chrysalis the world’s largest source of molybdenum-99 (Mo-99). By producing these isotopes at scale with fusion-driven systems, we’re demonstrating how our technology can make medical supply chains more secure while supporting patient care globally. The Nuclear Regulatory Commission is licensing Chrysalis under its Part 50 framework, the same rigorous code used for nuclear reactors. It’s the first advanced nuclear facility in decades to be approved through this process.

Advancing the radiochemistry expertise developed through our fusion work, Cassiopeia produces Ilumira, our 99.9%-pure, non-carrier-added lutetium-177 for cancer treatments. Ilumira’s high isotope purity enables more precise, reliable dosing that supports safer, more predictable care. With growing partnerships, we’re supporting clinical trials and treatment programs worldwide.

From aircraft engines to semiconductor chips, mission-critical components must be proven safe before operation. We’re delivering the proof at an industrial scale.

Built on our core fusion technology, FLARE is a service that tests and validates materials for aerospace, defense, and advanced energy applications. Launched in 2024, it delivers steady 14 MeV fusion neutrons—the same conditions materials experience in nuclear and space environments. ‍ FLARE quickly gives customers the data they need to design and qualify mission-critical systems. Early contracts with the U.S. Department of Defense and leading aerospace companies highlight its emergence as the new standard in radiation-effects testing.

Built on the accelerator technology that underpins our fusion platform, the Phoenix Imaging Center has become the nation’s premier neutron-imaging service provider for aerospace and defense customers. Operating since 2020, it uses thermal and fast neutron beams—with CT capability—to detect flaws invisible to X-rays.

Grounded in our fusion-based neutron technology, our fuel-scanning systems help ensure the safety and quality of nuclear fuel before it ever reaches a reactor. These systems use neutrons to see through materials too dense for X-rays, verifying that each fuel rod meets exacting standards for structure and composition. ‍ Equipment designed and built by SHINE has inspected nearly half of the fuel rods operating in the United States—a clear demonstration of our precision engineering and performance at scale.

We’re applying our fusion and radiochemistry expertise to one of energy’s biggest challenges: used nuclear fuel. Our REDUCE process aims to recover value from spent fuel, a resource that still contains most of its original energy. Supported by the ARPA-E program and leading industry partners, this approach could redefine how nuclear waste is managed.

Recover Value : We aim to retrieve uranium and plutonium that can re-enter the fuel cycle as new fuel, potentially recapturing ≈96% of the mass now treated as waste. ‍ Reclaim Materials : We plan to isolate valuable elements such as strontium-90, rhodium, and americium-241 for use in medicine, manufacturing, and advanced-energy systems. ‍ ‍ Reduce Waste : We intend to use fusion neutrons to transform the small remaining fraction into stable or shorter-lived forms, reducing storage needs from millennia to decades.

Fusion energy can deliver nearly limitless, carbon-free power without long-lived waste or meltdown risk. Our fusion systems already apply the same physics and engineering principles that future energy sources could depend on. This is how we're building toward clean fusion energy at industrial scale.

Artemis powers FLARE, our radiation-effects testing service. It produces 14 MeV neutrons, creating the environment used to test and qualify materials for fusion, defense, and space exploration applications.

Our internal research and collaborative studies focus on increasing neutron intensity, improving energy efficiency, and advancing tritium-management and materials systems—all aimed at preparing our fusion platform for future energy production.

Our technology isn’t a distant vision. It’s saving lives, strengthening national security, and advancing the science for making clean fusion energy possible. ‍ Fusion can deliver value today, generate long-term growth, and help build a new energy economy for tomorrow.

Our vision is to transform humankind through fusion technology and its vast potential to create a safer, healthier, cleaner world.

Rather than just talk about what we’ll do someday, we deliver measurable results every week. That’s because we run revenue-generating fusion systems right now that provide vital products and services to paying customers. Our market-first approach lets us reinvest in our capabilities and continue to improve. That’s how we plan to achieve our ultimate goal: to produce clean, abundant fusion energy at scale.

Our progress in fusion is documented, regulated, and repeatable. Our technology operates reliably, scales safely, and has gained regulatory confidence in real markets:

Where SHINE Technologies sits

Composed from records in this dataset, not from outside research. Every figure below is counted from what the site holds, so it moves when the data does.

SHINE Technologies is one of 3 organisations in this dataset pursuing beam-target.

It is one of 103 we hold in US.

Related organisations

Others pursuing the same approach, then others in the same country.

Pursuing the same technology

Others in this dataset working on Beam-target.

Sources

A source marked operator is the subject’s own publication. That is legitimate, and it is not independent confirmation. Methodology.